MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

PURPOSE: Chronic hepatitis B (CHB) and metabolic associated fatty liver disease (MAFLD) are both important public health problems. The effect of concomitant MAFLD on patients with CHB is still unclear. This study aimed to explore the influence of MAFLD on liver fibrosis and inflammation in CHB patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoman, Zhou, Jing, Wu, Lili, Zhu, Xiang, Deng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898022/
https://www.ncbi.nlm.nih.gov/pubmed/35256849
http://dx.doi.org/10.2147/DMSO.S351492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898022/
https://www.ncbi.nlm.nih.gov/pubmed/35256849
http://dx.doi.org/10.2147/DMSO.S351492

Ejemplares similares